US trade sources tell FBN there will be historic purchases announced in agreement with China. Both sides will also exempt more agriculture products, medical supplies, and lo-tech electronics from additional tariffs

Sourced-but-unconfirmed trade headlines of this kind have been a recurring feature of US-China negotiation cycles, and the established pattern is a two-stage reaction: an initial risk-positive move on the headline itself, followed by partial retracement once the text, the purchase figures, and the enforcement mechanism are actually published. The distinction that has mattered historically is between purchase commitments, which are aspirational and front-loaded into ag futures and the soy complex, and tariff exemptions, which carry the more durable signal since they mark de-escalation in the existing schedule rather than promises about the future. The channels are well worn: China-sensitive ags and the associated freight and basis, the antipodean and trade-beta FX against the dollar, and the yuan as the cleanest expression of deal credibility. Attribution to a single outlet's sources rather than both governments is worth noting; jointly confirmed announcements have historically held their moves better than one-sided leaks, which have on occasion been walked back or diluted. The follow-ons that separate durable repricing from a fade are official confirmation from both sides, any written text or signing date, and whether the exemptions are framed as mutual and structural or as temporary good-will gestures.